Molecular Mechanisms and Potential Rationale of Immunotherapy in Peritoneal Metastasis of Advanced Gastric Cancer.

Biomedicines · 2022 · PMC9220323 · PMID 35740397

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This study showed a trend toward the superiority of intraperitoneal catumaxomab, but the difference of mCR rates was not statistically significant (mCR rates, 27% vs. 19%, p = 0.69).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.